Home » Reva Receives CE Mark for Fantom Encore Bioresorbable Scaffold
Reva Receives CE Mark for Fantom Encore Bioresorbable Scaffold
Reva received a CE mark and reported the first implant of the Fantom Encore bioresorbable scaffold.
Bioresorbable scaffolds were developed as an alternative to metal drug-eluting stents for the treatment of coronary artery disease. The Fantom Encore offers a thin profile without compromising strength or X-ray visibility, using improved polymer processing and manufacturing techniques.
REVA expects to launch the entire Fantom Encore product line later this year.
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May